betamethasone has been researched along with propranolol in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Carrupt, PA; Martel, S; Ottaviani, G | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Häggendal, E; Hellman, A; Lindfors, M; Lundberg, D | 1 |
| Aguayo, J; Baeza, A; Barria, M; Pineda, G | 1 |
| Gaind, ML; Seth, HN; Sharma, NN; Singh, I | 1 |
| Benedetto, N; Folgore, A; Galdiero, M | 1 |
| Benedetto, N; Ferrara, C; Folgore, A; Galdiero, M | 1 |
| Alonso, SJ; Castellano, MA; Martín, FA; Navarro, E | 1 |
| Cui, L; Guo, Y; Hong, ZJ; Jiang, HQ; Yuan, SM; Zhang, M | 1 |
| Li, J; Shao, RZ; Zhao, DH | 1 |
| Wang, M; Xu, MN; Xu, Y; Yuan, SM; Zhang, M | 1 |
| Liu, JW; Ma, DL | 1 |
| Chang, HF; Chang, L; Chang, SJ; Lin, X; Qiu, Y; Shang, Y | 1 |
24 other study(ies) available for betamethasone and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Haemodynamic effects of different corticosteroids in controlled haemorrhagic shock in the dog.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Aldosterone; Animals; Betamethasone; Cardiac Output; Dogs; Drug Evaluation, Preclinical; Drug Interactions; Female; Hemodynamics; Hydrocortisone; Male; Methylprednisolone; Oxygen Consumption; Phenoxybenzamine; Propranolol; Shock, Hemorrhagic; Sodium Chloride; Succinates; Vasodilation | 1978 |
Rapid preoperative preparation in hyperthyroidism.
Topics: Adolescent; Adult; Betamethasone; Drug Administration Schedule; Female; Humans; Hyperthyroidism; Iopanoic Acid; Male; Middle Aged; Pregnancy; Pregnancy Complications; Preoperative Care; Propranolol; Thyroidectomy; Thyroxine; Time Factors; Triiodothyronine; Triiodothyronine, Reverse | 1991 |
Corticosteroid-sparing effect of -adrenergic blocking agents in pemphigus vulgaris.
Topics: Adrenergic beta-Antagonists; Adult; Betamethasone; Child; Female; Glucocorticoids; Humans; Male; Middle Aged; Pemphigus; Propranolol | 1973 |
Impairment of natural resistance to Toxoplasma gondii infection in rats treated with beta adrenergics, beta blockers, corticosteroids or total body irradiation.
Topics: Animals; Antigens, Surface; Betamethasone; Epinephrine; Immunity, Innate; Propranolol; Rats; Rats, Inbred F344; T-Lymphocytes; Toxoplasmosis, Animal; Whole-Body Irradiation | 1993 |
Susceptibility to toxoplasmosis: correlation between macrophage function, brain cyst formation and mortality in rats.
Topics: Adrenergic beta-Antagonists; Animals; Betamethasone; Brain Diseases; Cysts; Disease Susceptibility; Glucocorticoids; Immunosuppression Therapy; Macrophages, Peritoneal; Male; Propranolol; Rats; Rats, Inbred F344; Toxoplasmosis, Animal; Whole-Body Irradiation | 1996 |
Toxicological and pharmacological effects of D-arginine.
Topics: Adrenergic beta-Antagonists; Animals; Arginine; Autonomic Nervous System; Behavior, Animal; Betamethasone; Central Nervous System; Dose-Response Relationship, Drug; Drug Interactions; Hypnotics and Sedatives; Male; Mice; Motor Activity; Pentylenetetrazole; Phenobarbital; Propranolol; Seizures; Sleep | 2005 |
Intralesional injection of diprospan is effective for infantile hemangioma.
Topics: Betamethasone; Drug Combinations; Female; Follow-Up Studies; Glucocorticoids; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Propranolol; Remission Induction; Skin Neoplasms; Soft Tissue Neoplasms; Torso; Upper Extremity | 2015 |
Treatment of infantile hemangioma by intralesional injection of propranolol combined with compound betamethasone.
Topics: Betamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Injections, Intralesional; Male; Propranolol; Skin Neoplasms; Treatment Outcome | 2016 |
Individualized Treatment for Infantile Hemangioma.
Topics: Administration, Cutaneous; Administration, Oral; Betamethasone; Carteolol; Female; Glucocorticoids; Hemangioma, Capillary; Humans; Infant; Injections, Intralesional; Male; Neoplastic Syndromes, Hereditary; Propranolol; Treatment Outcome; Vasodilator Agents | 2018 |
Image Gallery: Nodular pretibial myxoedema.
Topics: Administration, Cutaneous; Adult; Betamethasone; Biopsy; Drug Therapy, Combination; Humans; Hyperthyroidism; Leg Dermatoses; Male; Methimazole; Myxedema; Occlusive Dressings; Propranolol; Skin; Treatment Outcome | 2019 |
Intralesional betamethasone versus oral propranolol for localized infantile hemangiomas of the lip.
Topics: Adrenergic beta-Antagonists; Betamethasone; Child; Hemangioma; Humans; Infant; Lip; Propranolol; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2023 |